Senior insider sale
EVP, Chf GL Pdt Str Ofcr at IONIS PHARMACEUTICALS INC — senior position signals high conviction
$3.34M
44K shares
What this filing means
JENNE KYLE plans to sell 44K shares of IONIS PHARMACEUTICALS INC valued at approximately $3.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/16/2026ACC: 0000874015-26-000164
Officer· EVP, Chf GL Pdt Str Ofcr
Since Mar 2026
44K
Shares to sell
$3.34M
Approx. market value
4.90K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSUs granted under 2011 Equity Incentive Plan
Compensation
4/15/2026
4.90KTotal acquired4.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/15/2026 | RSUs granted under 2011 Equity Incentive Plan Compensation | 4.90K | — |
| Total | 4.90K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
37.28K
Market value
$2.83M
3/10/2026
—Completed
Units to sell
1.82K
Market value
$138.5K
1/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.90K
Market value
$369.6K
4/16/2026
Total
Units
44K
Value
$3.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 37.28K | $2.83M | — | Completed |
1/16/2026 | 1.82K | $138.5K | — | Completed |
| Planned — Approximate Date | ||||
4/16/2026 | 4.90K | $369.6K | NASDAQ | Planned |
| Total | 44K | $3.34M | ||